Related Experiment Video
Updated: Jul 11, 2025

Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
Long-term clinical outcomes after initial secondary pneumothorax surgery
Mi Hyoung Moon1, Kyung Soo Kim1, Seok Whan Moon1
1Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Secondary pneumothorax (SP) recurrence is higher in patients with lung disease other than chronic obstructive pulmonary disease (COPD). Non-COPD lung conditions are a significant risk factor for SP recurrence after surgery.
Area of Science:
- Thoracic Surgery
- Pulmonary Medicine
- Clinical Research
Background:
- Secondary pneumothorax (SP) presents treatment challenges due to diverse lung diseases and surgical risks.
- Standardizing care and early surgical intervention for SP are complex.
- Understanding SP recurrence is crucial for effective patient management.
Purpose of the Study:
- To document the clinical course of SP following initial surgical treatment.
- To analyze the risk factors associated with SP recurrence.
- To identify predictors of postsurgical pneumothorax recurrence.
Main Methods:
- Retrospective review of 160 patients with SP.
- Analysis of clinical, imaging, and operative data from an institutional database.
- Cox proportional hazards (PH) analysis to determine recurrence risk factors.
Main Results:
- Overall recurrence rate was 18.75% over a mean follow-up of 58.7 months.
- Underlying lung pathology other than COPD was the strongest predictor of recurrence (HR=5.3, P<0.001).
- Some patients experienced multiple pneumothorax episodes before surgery, particularly those without COPD.
Conclusions:
- Non-COPD lung disease is a confirmed risk factor for postsurgical SP recurrence.
- Frequent pneumothorax episodes may occur, especially in the absence of COPD.
- Consideration of underlying lung pathology is essential for treatment planning in SP.
Related Concept Videos
Pneumothorax-II
Clinical Manifestations:
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:
Endoscopic Studies II: Thoracocentesis
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Endoscopic Studies I: Bronchoscopy and Thoracoscopy
Bronchoscopy
Description
Bronchoscopy is a procedure that involves direct visualization of the larynx, trachea, and bronchi for diagnostic and therapeutic purposes. A flexible fiber optic or rigid bronchoscope is used to carry out the procedure. The fiber-optic bronchoscope is more frequently used due...
Pneumothorax-I
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:

